Insiders · COGT

COGT insider transactions

Cogent Biosciences Inc. (COGT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

COGT insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Cogent Biosciences Inc., latest first. Follow anyone to get their next filing.

• Arlene MorrisDirector-$1.69M
• Karen Jean FerranteDirector
• Andrew R RobbinsPresident and CEO, Director
• Fairmount Funds Management LLCDirector+$44.5M-$370M
• Evan KearnsChief Legal Officer, since May 2021-$2.52M
• John L. GreenChief Financial Officer-$3.14M
• John Edward RobinsonChief Scientific Officer, since March 2021-$3.49M
• Jessica SachsChief Medical Officer-$3.2M
• Cole PinnowChief Commercial Officer, since May 2024+$332K
• Christopher W. CainDirector
• Matthew RosDirector
• Todd ShegogDirector, since February 2021
• Peter Evan HarwinDirector

Recent Form 3, 4, and 5 filings for COGT

• 34d
  SEC Form 4 filed by Cogent Biosciences Inc.

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 69d
  Director Morris Arlene exercised 45,510 shares at a strike of $5.39 and sold $1,689,493 worth of shares (45,510 units at $37.12) as part of a pre-agreed trading plan (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 125d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 171d
  President and CEO Robbins Andrew R received a gift of 160,000 shares and gifted 160,000 shares, decreasing direct ownership by 24% to 497,503 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 219d
  SEC Form 4 filed by Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 222d
  SEC Form 4 filed by Fairmount Funds Management Llc

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 290d
  Director Fairmount Funds Management Llc sold $127,400,000 worth of shares (3,500,000 units at $36.40) (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 307d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 313d
  Chief Financial Officer Green John L. sold $2,978,360 worth of shares (77,000 units at $38.68), decreasing direct ownership by 37% to 131,834 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 313d
  Chief Medical Officer Sachs Jessica sold $3,198,245 worth of shares (82,642 units at $38.70), decreasing direct ownership by 38% to 133,938 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 313d
  Chief Legal Officer Kearns Evan sold $2,515,500 worth of shares (65,000 units at $38.70), decreasing direct ownership by 37% to 109,398 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 313d
  Chief Scientific Officer Robinson John Edward sold $3,486,600 worth of shares (90,000 units at $38.74), decreasing direct ownership by 39% to 140,002 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 324d
  Chief Scientific Officer Robinson John Edward was granted 370,000 shares and covered exercise/tax liability with 139,998 shares (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 324d
  Chief Financial Officer Green John L. was granted 350,000 shares and covered exercise/tax liability with 145,007 shares, increasing direct ownership by 5,337% to 208,834 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 324d
  Chief Legal Officer Kearns Evan covered exercise/tax liability with 125,602 shares and was granted 300,000 shares (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 324d
  Chief Medical Officer Sachs Jessica was granted 370,000 shares and covered exercise/tax liability with 154,716 shares, increasing direct ownership by 16,611% to 216,580 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 324d
  Chief Commercial Officer Pinnow Cole covered exercise/tax liability with 94,800 shares and was granted 264,000 shares, increasing direct ownership by 357% to 216,650 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 324d
  President and CEO Robbins Andrew R was granted 1,025,000 shares and covered exercise/tax liability with 367,497 shares (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 401d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 482d
  Director Fairmount Funds Management Llc bought $24,999,993 worth of shares (2,777,777 units at $9.00) (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 494d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 521d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 521d
  SEC Form 4 filed by Director Cain Christopher W.

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 521d
  SEC Form 4 filed by Director Ros Matthew

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 521d
  SEC Form 4 filed by Director Shegog Todd

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 521d
  SEC Form 4 filed by Director Harwin Peter Evan

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 521d
  SEC Form 4 filed by Director Morris Arlene

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 584d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 650d
  SEC Form 4 filed by Chief Financial Officer Green John L.

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 650d
  SEC Form 4 filed by Chief Commercial Officer Pinnow Cole

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 650d
  SEC Form 4 filed by Chief Scientific Officer Robinson John Edward

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 650d
  SEC Form 4 filed by Chief Medical Officer Sachs Jessica

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 650d
  SEC Form 4 filed by President and CEO Robbins Andrew R

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 650d
  SEC Form 4 filed by Chief Legal Officer Kearns Evan

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 662d
  Chief Commercial Officer Pinnow Cole bought $332,412 worth of shares (43,750 units at $7.60), increasing direct ownership by 2,085% to 45,848 units (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 674d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 767d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 859d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 878d
  SEC Form 4 filed by Director Cain Christopher W.

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 878d
  SEC Form 4 filed by Director Ros Matthew

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 878d
  SEC Form 4 filed by Director Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 878d
  SEC Form 4 filed by Director Harwin Peter Evan

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 878d
  SEC Form 4 filed by Director Shegog Todd

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 878d
  SEC Form 4 filed by Director Morris Arlene

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 879d
  Director Fairmount Funds Management Llc converted options into 1,500,000 shares (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 893d
  SEC Form 4 filed by Pinnow Cole

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 893d
  New insider Pinnow Cole claimed ownership of 700 shares (SEC Form 3)

  3 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 950d
  SEC Form 4 filed by Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 951d
  Fairmount Funds Management Llc disposed of 286,851 shares and acquired 286,851 shares (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 996d
  Fairmount Funds Management Llc was granted 1,166,666 shares (SEC Form 4)

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1018d
  SEC Form 4 filed by Robinson John Edward

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1018d
  SEC Form 4 filed by Kearns Evan

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1018d
  SEC Form 4 filed by Sachs Jessica

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1018d
  SEC Form 4 filed by Robbins Andrew R

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1018d
  SEC Form 4 filed by Green John L.

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1039d
  SEC Form 4 filed by Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1039d
  SEC Form 4 filed by Ros Matthew

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1132d
  SEC Form 4 filed by Ros Matthew

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1132d
  SEC Form 4 filed by Ferrante Karen Jean

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)
• 1222d
  SEC Form 4 filed by Ros Matthew

  4 - Cogent Biosciences, Inc. (0001622229) (Issuer)